ITACITINIB |
ITACITINIB : Inhibitor of JAK1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| JAK1 |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity within target family: Itacitinib was a selective JAK1 inhibitor with an IC50 value of 3. ...
Selectivity Assessment Description:
At a test concentration of 100 nM, itacitinib did not show significant inhibition (<30% inhibition) ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
Thrombopoietin induced STAT3 phosphorylation of PBMC: 913 ± 87 nM.
Selectivity Assessment Description:
JAK2 specific thrombopoietin induced STAT3 phosphorylation required >10 fold higher itacitinib conce ...
Potency Cellular
In Vitro
JAK1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1016/j.ejphar.2020.173505
In Vivo Validations
Mouse
Dose: 20, 40, and 80 mg/k
Route of delivery:
Oral
Cmax:
1361, 1800, 7025 nM
Area Under the Curve::
2609, 3783,10784 uM*h
DOI Reference: 10.1016/j.ejphar.2020.173505
Chemical Information
| Molecular Formula | C26H23F4N9O |
| InChI | InChI=1S/C26H23F4N9O/c27-20-18(1-7-32-22(20)26(28,29)30)24(40)37-9-3-17(4-10-37)38-13-25(14-38,5-6-31)39-12-16(11-36-39)21-19-2-8-33-23(19)35-15-34-21/h1-2,7-8,11-12,15,17H,3-5,9-10,13-14H2,(H,33,34,35) |